VRTXPartnership•businesswire•
Enlaza Therapeutics Announces Strategic Collaboration with Vertex Pharmaceuticals to Develop War-Lock Drug Conjugates and T-Cell Engagers for Improved Conditioning and Certain Autoimmune Diseases
Sentiment:Neutral (60)
Summary
(NASDAQ:VRTX) LA JOLLA, Calif.--(BUSINESS WIRE)-- #ADC--Enlaza Therapeutics Announces Strategic Collaboration with Vertex Pharmaceuticals
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 2, 2025 by businesswire